Type 1 Diabetes (T1D) is a chronic autoimmune disease with lifelong implications for patients, requiring constant clinical attention and innovation in care. The management of T1D has profoundly evolved thanks to technological advances, improved insulin therapies, and novel approaches aimed at preventing acute and chronic complications.
This course, designed under the scientific guidance of Prof. Paolo Fiorina, provides an up-to-date and comprehensive overview of T1D management. Starting from diagnosis and classification, it covers advanced glucose monitoring systems (CGM, insulin pumps), strategies for preventing hypoglycemia and diabetic ketoacidosis, and the long-term management of chronic complications. In addition, the course delves into insulin regimens tailored to clinical practice and explores cutting-edge approaches such as advanced cellular therapies.
Through a clinically oriented and evidence-based perspective, the program aims to provide healthcare professionals with the knowledge and tools necessary to optimize patient outcomes and stay aligned with the latest scientific and technological advances in Type 1 Diabetes care.
Type 1 Diabetes: a comprehensive guide for clinical practice
Type 1 Diabetes (T1D) is a chronic autoimmune disease with lifelong implications for patients, requiring constant clinical attention and innovation in care. The management of T1D has profoundly evolved thanks to technological advances, improved insulin therapies, and novel approaches aimed at preventing acute and chronic complications.
This course, designed under the scientific guidance of Prof. Paolo Fiorina, provides an up-to-date and comprehensive overview of T1D management. Starting from diagnosis and classification, it covers advanced glucose monitoring systems (CGM, insulin pumps), strategies for preventing hypoglycemia and diabetic ketoacidosis, and the long-term management of chronic complications. In addition, the course delves into insulin regimens tailored to clinical practice and explores cutting-edge approaches such as advanced cellular therapies.
Through a clinically oriented and evidence-based perspective, the program aims to provide healthcare professionals with the knowledge and tools necessary to optimize patient outcomes and stay aligned with the latest scientific and technological advances in Type 1 Diabetes care.
Type 1 Diabetes: Diagnosis and Classification Overview
Advanced Glucose Monitoring: CGM and Emerging Technologies
Management of Acute Complications: Hypoglycemia and Diabetic Ketoacidosis
Preventing and Managing Chronic Complications in Type 1 Diabetes
Insulin Management in Type 1 Diabetes: Core Principles and Treatment Regimens
Advanced Cellular Therapies
Type 1 Diabetes (T1D) is a chronic autoimmune disease with lifelong implications for patients, requiring constant clinical attention and innovation in care. The management of T1D has profoundly evolved thanks to technological advances, improved insulin therapies, and novel approaches aimed at preventing acute and chronic complications.
This course, designed under the scientific guidance of Prof. Paolo Fiorina, provides an up-to-date and comprehensive overview of T1D management. Starting from diagnosis and classification, it covers advanced glucose monitoring systems (CGM, insulin pumps), strategies for preventing hypoglycemia and diabetic ketoacidosis, and the long-term management of chronic complications. In addition, the course delves into insulin regimens tailored to clinical practice and explores cutting-edge approaches such as advanced cellular therapies.
Through a clinically oriented and evidence-based perspective, the program aims to provide healthcare professionals with the knowledge and tools necessary to optimize patient outcomes and stay aligned with the latest scientific and technological advances in Type 1 Diabetes care.
Lesson coming soon
Supported by:
